BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 821420)

  • 1. [Study of the electrophysiological properties of bretylium tosylate in man].
    Touboul P; Porte J; Huerta F; Delahaye JP
    Arch Mal Coeur Vaiss; 1976 May; 69(5):503-11. PubMed ID: 821420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Electrophysiologic basis of the anti-arrhythmic action of amiodarone in man].
    Touboul P; Huerta F; Porte J; Delahaye JP
    Arch Mal Coeur Vaiss; 1976 Aug; 69(8):845-53. PubMed ID: 823922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiological effects of bretylium tosylate on subendocardial Purkinje fibers from infarcted canine hearts.
    Cardinal R; Sasyniuk BI
    J Pharmacol Exp Ther; 1978 Jan; 204(1):159-74. PubMed ID: 619127
    [No Abstract]   [Full Text] [Related]  

  • 4. [Action of chloro-acetyl-ajmaline on the electrical properties of the human heart].
    Touboul P; Jandot V; Thizy JF; Chatelain MT; Delahaye JP
    Arch Mal Coeur Vaiss; 1977 Sep; 70(9):973-80. PubMed ID: 415694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Action of bretylium tosylate in a single bolus and in different doses on various electrophysiological parameters].
    Chiariello M; Santinelli V; Ferro G; Stanislao M; Giunta A; Condorelli M
    Boll Soc Ital Cardiol; 1979; 24(7):747-51. PubMed ID: 554660
    [No Abstract]   [Full Text] [Related]  

  • 6. Postmyocardial infarction re-entrant ventricular arrhythmias in conscious dogs: suppression by bretylium tosylate.
    Patterson E; Gibson JK; Lucchesi BR
    J Pharmacol Exp Ther; 1981 Mar; 216(3):453-8. PubMed ID: 7205624
    [No Abstract]   [Full Text] [Related]  

  • 7. [Electrophysiologic effects of lorcainide (R 15889) in man].
    Touboul P; Atallah G; Kirkorian G
    Arch Mal Coeur Vaiss; 1981 Nov; 74(11):1333-40. PubMed ID: 6797372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency-dependent effects of antiarrhythmic drugs on action potential duration and refractoriness of canine cardiac Purkinje fibers.
    Nattel S; Zeng FD
    J Pharmacol Exp Ther; 1984 Apr; 229(1):283-91. PubMed ID: 6707943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiologic effects of bretylium tosylate on the heart.
    Waxman MB; Wallace AG
    J Pharmacol Exp Ther; 1972 Nov; 183(2):264-74. PubMed ID: 5083545
    [No Abstract]   [Full Text] [Related]  

  • 10. [Electrophysiologic effects of amiodarone in Wolf-Parkinson-White syndrome].
    Touboul P; Porte J; Huerta F; Delahaye JP
    Arch Mal Coeur Vaiss; 1976 Aug; 69(8):855-63. PubMed ID: 823923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane action and catecholamine release action of bretylium tosylate in normoxic and hypoxic canine Purkinje fibers.
    Nishimura M; Watanabe Y
    J Am Coll Cardiol; 1983 Aug; 2(2):287-95. PubMed ID: 6863763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bretylium tosylate--induced stabilization of electrical systole duration in patients with acute myocardial infarction.
    Jouve R; Puddu PE; Torresani J
    Heart Lung; 1982; 11(5):399-405. PubMed ID: 6921188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of the electrophysiological effects of amiodarone using simultaneous recordings of monophasic and bundle-of-his action potentials].
    Cabasson J; Puech P; Mellet JM; Guimond C; Bachy C; Sassine A
    Arch Mal Coeur Vaiss; 1976 Jul; 69(7):691-9. PubMed ID: 821440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiologic effects of bretylium tosylate on the canine heart during coronary artery occlusion and reperfusion.
    Gibson JK; Stewart JR; Li YP; Lucchesi BR
    J Cardiovasc Pharmacol; 1983; 5(4):517-24. PubMed ID: 6193345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bretylium tosylate: profile of the only available class III antiarrhythmic agent.
    Anderson JL
    Clin Ther; 1985; 7(2):205-24. PubMed ID: 3886143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Electrophysiological effects of anti-arrhythmia agents in man. Attempt at classification].
    Touboul P; Attalah G; Gressard A; Michelon G; Chatelain MT; Delahaye JP
    Arch Mal Coeur Vaiss; 1979 Jan; 72(1):72-81. PubMed ID: 107885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of bretylium tosylat on the human atrio-ventricular and intraventricular conduction].
    Abate G; ZacĂ  F; Polimeni RM; Alberici S
    Boll Soc Ital Cardiol; 1976; 21(4):601-8. PubMed ID: 1031024
    [No Abstract]   [Full Text] [Related]  

  • 18. [Influence of propafenon on hemodynamics of the left ventricle and atrioventricular conduction with special reference to the WPW syndrome].
    Probst P; Pachinger O
    Z Kardiol; 1976 Mar; 65(3):213-24. PubMed ID: 1258514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiological effects of penticainide in the anaesthetized dog.
    Sassine A; Brugada J; Munoz A; Romero-Ayala L; Masse C
    Drugs Exp Clin Res; 1987; 13(1):15-20. PubMed ID: 3595440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of bretylium on rat cardiac muscle: the electrophysiological effects and its uptake and binding in normal and immunosympathectomized rat hearts.
    Namm DH; Wang CM; El-Sayad S; Copp FC; Maxwell RA
    J Pharmacol Exp Ther; 1975 Apr; 193(1):194-208. PubMed ID: 1133764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.